Skip to main content

Table 2 Multivariate analysis of risk factors associated with scarring alopecia

From: Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus

Risk factors OR (95%CI) p value
Smoking 1.853 (0.985~3.488) 0.056
SCLICC/ACR-DI (exclude chronic scarring alopecia) 1.409 (1.207~1.646) < 0.001***
Anti-Sm 1.374 (1.034~1.825) 0.029*
Anti-rRNP 0.808 (0.590~1.108) 0.186
Anti-RNP 1.007 (0.744~1.362) 0.964
Mucocutaneous 2.062 (1.536~2.767) < 0.001***
Renal 0.714 (0.529~0.964) 0.028*
Cardio-respiratory 0.347 (0.123~0.970) 0.044*
Glucocorticoid 1.196 (0.800~1.789) 0.383
Immunosuppressantsa 0.675 (0.505~0.901) 0.008**
  1. SLICC/ACR-DI Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index, ANA Antinuclear antibody, anti-Sm anti-Smith, anti-rRNP anti-ribosomal P protein, anti-RNP anti-ribonucleoprotein
  2. *p < 0.05; **p < 0.01; ***p < 0.001
  3. aImmunosuppressants included cyclophosphamide, mycophenolate mofetil, azathioprine, cyclosporine, tacrolimus
\